Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CATB | AMGN | GILD | CELG | VRTX |
Company | Catabasis Pharma | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 9.21 | 270.00 | 73.69 | 108.01 | 410.49 |
High | 9.21 | 273.58 | 74.17 | 108.59 | 415.50 |
Low | 8.46 | 269.21 | 73.21 | 107.27 | 409.24 |
Last | 8.54 | 270.90 | 73.26 | 108.24 | 411.38 |
Change | -0.64 | +2.03 | -0.43 | +0.11 | +3.69 |
% Change | -6.97% | +0.76% | -0.58% | +0.10% | +0.91% |
Volume | 98,800 | 3,608,400 | 6,939,600 | 191,230,496 | 926,400 |
20-Day Average Volume | 395,311 | 3,167,750 | 7,194,110 | 16,188,930 | 1,062,215 |
Previous Close | 9.18 | 268.87 | 73.69 | 108.13 | 407.69 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | No | Yes |
Technicals | |||||
20-Day Moving Average | 8.72 | 277.81 | 73.44 | 108.17 | 419.27 |
20-Day Raw Stochastic | 56.46% | 11.34% | 38.03% | 63.25% | 14.69% |
20-Day Relative Strength | 43.24% | 37.45% | 43.28% | 64.69% | 46.10% |
Weighted Alpha | -50.43 | +11.20 | -10.00 | +46.30 | +28.80 |
Today's Opinion | 88% Sell | 8% Sell | 88% Sell | 100% Buy | 40% Buy |
Previous Opinion | 72% Sell | 8% Sell | 72% Sell | 100% Buy | 40% Buy |
Last Month's Opinion | 100% Sell | 56% Buy | 40% Sell | 100% Buy | 80% Buy |
Performance | |||||
5-Days | |||||
%Chg | -14.34% since 08/31/21 | -1.62% since 03/11/24 | -2.73% since 03/11/24 | -1.97% since 11/13/19 | -0.75% since 03/11/24 |
Low | 8.46 on 09/08/21 | 268.17 on 03/15/24 | 73.21 on 03/18/24 | 107.27 on 11/20/19 | 406.97 on 03/15/24 |
High | 10.26 on 09/02/21 | 278.56 on 03/13/24 | 76.18 on 03/13/24 | 110.53 on 11/14/19 | 416.11 on 03/12/24 |
1-Month | |||||
%Chg | -8.17% since 08/06/21 | -4.51% since 02/16/24 | +2.35% since 02/16/24 | +5.14% since 10/18/19 | -2.56% since 02/16/24 |
Low | 6.31 on 08/20/21 | 268.17 on 03/15/24 | 71.45 on 02/20/24 | 102.40 on 10/21/19 | 406.97 on 03/15/24 |
High | 10.26 on 09/02/21 | 292.24 on 02/23/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 437.00 on 02/27/24 |
3-Month | |||||
%Chg | -34.10% since 06/08/21 | -1.66% since 12/18/23 | -7.85% since 12/18/23 | +13.63% since 08/20/19 | +1.66% since 12/18/23 |
Low | 6.31 on 08/20/21 | 268.17 on 03/15/24 | 71.37 on 02/16/24 | 93.41 on 08/23/19 | 395.01 on 12/19/23 |
High | 15.72 on 06/16/21 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
6-Month | |||||
%Chg | -50.23% since 03/08/21 | +2.95% since 09/18/23 | -3.12% since 09/18/23 | +14.14% since 05/20/19 | +16.87% since 09/18/23 |
Low | 6.31 on 08/20/21 | 249.70 on 10/31/23 | 71.37 on 02/16/24 | 89.08 on 07/23/19 | 341.85 on 10/03/23 |
High | 22.01 on 03/18/21 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
Key Statistics | |||||
Market Capitalization, $K | 33,337 | 144,092,544 | 91,801,160 | 77,035,920 | 105,309,592 |
Shares Outstanding, K | 3,904 | 535,919 | 1,245,775 | 711,714 | 258,308 |
Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
Annual Net Income | -37,300,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
Last Quarter Net Income | -7,470,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
60-Month Beta | 1.66 | 0.58 | 0.18 | 1.41 | 0.35 |
Per-Share Information | |||||
Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
Latest Earnings Date | 08/09/21 | 04/25/24 | 04/25/24 | 10/31/19 | 05/06/24 |
Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 14.56 | 11.04 | 10.99 | 30.41 |